Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients

2001-04-07

The Lancet , Volume 357 - Issue 9262 p. 1096- 1097

Additional Metadata
Persistent URL	doi.org/10.1016/S0140-6736(00)04311-7, hdl.handle.net/1765/57182
Journal	The Lancet
Organisation	Department of Pediatrics
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Menges, M. J., Hermans, P., Little, S., Langefeld, C., Böning, O., Engel, J., … Hempelmann, G. (2001). Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients. The Lancet, 357(9262), 1096–1097. doi:10.1016/S0140-6736(00)04311-7

Publication